Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children

• Main Authors: Nginache Nampota-Nkomba (Author), Osward M. Nyirenda (Author), Victoria Mapemba (Author), Rhoda Masonga (Author), Priyanka D. Patel (Author), Theresa Misiri (Author), Felistas Mwakiseghile (Author), Richard Wachepa (Author), John M. Ndaferankhande (Author), Bright Lipenga (Author), Pratiksha Patel (Author), Happy Banda (Author), Jennifer Oshinsky (Author), Marcela F. Pasetti (Author), Robert S. Heyderman (Author), Leslie P. Jamka (Author), Divya Hosangadi (Author), Shrimati Datta (Author), Melita A. Gordon (Author), Kathleen M. Neuzil (Author), Matthew B. Laurens (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Vaccine safety and immunogenicity data in human immunodeficiency virus (HIV)-exposed uninfected (HEU) children are important for decision-making in HIV and typhoid co-endemic countries. In an open-label study, we recruited Malawian HEU and HIV unexposed uninfected (HUU) infants aged 9 - 11 months. H...